Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -171.6% | +9.3% | 2 / 3 | -99.8% | -32.50 pp | -39610.25 pp | +17.7% | 0.11 | 2.57 | 0,1 | −99,8% | −28,1 | −175,1% | 2.57 | 3.25 | −21,0% |
| Pts | 0 | 0 | 8 | 0 | 0 | 0 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 6.820 (close price on 2026-10-19)EPS (TTM): 2.656
Financial charts
1.Revenue & growth
VND bn0,07Q2/26
1.Revenue & growth
VND bn0,07Q2/26
2.Profit & growth
VND bn-28,0Q2/26
3.Profit mix (Penman)
VND bn142Q2/26
4.Margins & cost structure
%11.8%Q2/26
5.Returns & cash cycle
% · days-2.3%Q2/26
6.Earnings quality & cash
VND bn369Q2/26
7.Asset structure
VND bn694Q2/26
8.Funding & debt health
VND bn · times694Q2/26
9.Revenue backlog
VND bn0,07Q2/26
10.Valuation
times · %2,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-643Q2/26
Adjusted EPS growth, latest quarter
-175%
Average adjusted EPS growth, 3 quarters
-37.9%
averaged over 2 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26